Patent · US Active

Anti-OX40 antibody

US11440965B2 · kind B2 · utility

0Cited by
0References
34Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 12, 2018
Grant dateSep 13, 2022
Priority date—
Expiry dateDec 12, 2038

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Provided is an isolated antibody or antigen binding fragment thereof. The isolated antibody or antigen binding fragment thereof can be used to prepare a medicament for treating tumors.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.